294 related articles for article (PubMed ID: 23499879)
1. Ursolic acid in cancer prevention and treatment: molecular targets, pharmacokinetics and clinical studies.
Shanmugam MK; Dai X; Kumar AP; Tan BK; Sethi G; Bishayee A
Biochem Pharmacol; 2013 Jun; 85(11):1579-87. PubMed ID: 23499879
[TBL] [Abstract][Full Text] [Related]
2. Mangiferin in cancer chemoprevention and treatment: pharmacokinetics and molecular targets.
Rajendran P; Rengarajan T; Nandakumar N; Divya H; Nishigaki I
J Recept Signal Transduct Res; 2015 Feb; 35(1):76-84. PubMed ID: 24984103
[TBL] [Abstract][Full Text] [Related]
3. Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: potential role in prevention and therapy of cancer.
Shanmugam MK; Nguyen AH; Kumar AP; Tan BK; Sethi G
Cancer Lett; 2012 Jul; 320(2):158-70. PubMed ID: 22406826
[TBL] [Abstract][Full Text] [Related]
4. Celastrol as a pentacyclic triterpenoid with chemopreventive properties.
Yadav P; Jaswal V; Sharma A; Kashyap D; Tuli HS; Garg VK; Das SK; Srinivas R
Pharm Pat Anal; 2018 Jul; 7(4):155-167. PubMed ID: 29882724
[TBL] [Abstract][Full Text] [Related]
5. Clinically useful anticancer, antitumor, and antiwrinkle agent, ursolic acid and related derivatives as medicinally important natural product.
Sultana N
J Enzyme Inhib Med Chem; 2011 Oct; 26(5):616-42. PubMed ID: 21417964
[TBL] [Abstract][Full Text] [Related]
6. Ursolic Acid-Based Derivatives as Potential Anti-Cancer Agents: An Update.
Khwaza V; Oyedeji OO; Aderibigbe BA
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824664
[TBL] [Abstract][Full Text] [Related]
7. Ursolic acid (UA): A metabolite with promising therapeutic potential.
Kashyap D; Tuli HS; Sharma AK
Life Sci; 2016 Feb; 146():201-13. PubMed ID: 26775565
[TBL] [Abstract][Full Text] [Related]
8. Ursolic Acid in Cancer Treatment and Metastatic Chemoprevention: From Synthesized Derivatives to Nanoformulations in Preclinical Studies.
Zou J; Lin J; Li C; Zhao R; Fan L; Yu J; Shao J
Curr Cancer Drug Targets; 2019; 19(4):245-256. PubMed ID: 30332961
[TBL] [Abstract][Full Text] [Related]
9. Advances in the Anticancer Value of the Ursolic Acid Through Nanodelivery.
Manayi A; Nikan M; Nobakht-Haghighi N; Abdollahi M
Curr Med Chem; 2018; 25(37):4866-4875. PubMed ID: 28707589
[TBL] [Abstract][Full Text] [Related]
10. Oleanolic acid and its synthetic derivatives for the prevention and therapy of cancer: preclinical and clinical evidence.
Shanmugam MK; Dai X; Kumar AP; Tan BK; Sethi G; Bishayee A
Cancer Lett; 2014 May; 346(2):206-16. PubMed ID: 24486850
[TBL] [Abstract][Full Text] [Related]
11. Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment.
Salvador JAR; Leal AS; Valdeira AS; Gonçalves BMF; Alho DPS; Figueiredo SAC; Silvestre SM; Mendes VIS
Eur J Med Chem; 2017 Dec; 142():95-130. PubMed ID: 28754470
[TBL] [Abstract][Full Text] [Related]
12. Ursolic acid: an anti- and pro-inflammatory triterpenoid.
Ikeda Y; Murakami A; Ohigashi H
Mol Nutr Food Res; 2008 Jan; 52(1):26-42. PubMed ID: 18203131
[TBL] [Abstract][Full Text] [Related]
13. Ursolic acid, a naturally occurring triterpenoid, suppresses migration and invasion of human breast cancer cells by modulating c-Jun N-terminal kinase, Akt and mammalian target of rapamycin signaling.
Yeh CT; Wu CH; Yen GC
Mol Nutr Food Res; 2010 Sep; 54(9):1285-95. PubMed ID: 20352621
[TBL] [Abstract][Full Text] [Related]
14. Pentacyclic triterpenoic acids: new chemoprotective compounds. Minireview.
Ovesná Z; Vachálková A; Horváthová K; Tóthová D
Neoplasma; 2004; 51(5):327-33. PubMed ID: 15640935
[TBL] [Abstract][Full Text] [Related]
15. Drug development for cancer chemoprevention: focus on molecular targets.
Johnson KA; Brown PH
Semin Oncol; 2010 Aug; 37(4):345-58. PubMed ID: 20816505
[TBL] [Abstract][Full Text] [Related]
16. Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials.
Shehzad A; Wahid F; Lee YS
Arch Pharm (Weinheim); 2010 Sep; 343(9):489-99. PubMed ID: 20726007
[TBL] [Abstract][Full Text] [Related]
17. Induction of apoptotic cell death by ursolic acid through mitochondrial death pathway and extrinsic death receptor pathway in MDA-MB-231 cells.
Kim KH; Seo HS; Choi HS; Choi I; Shin YC; Ko SG
Arch Pharm Res; 2011 Aug; 34(8):1363-72. PubMed ID: 21910059
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Potential of Ursolic Acid in Cancer and Diabetic Neuropathy Diseases.
Alam M; Ali S; Ahmed S; Elasbali AM; Adnan M; Islam A; Hassan MI; Yadav DK
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830043
[TBL] [Abstract][Full Text] [Related]
19. Ursolic Acid Analogs as Potential Therapeutics for Cancer.
Panda SS; Thangaraju M; Lokeshwar BL
Molecules; 2022 Dec; 27(24):. PubMed ID: 36558113
[TBL] [Abstract][Full Text] [Related]
20. Triterpenoids as new promising anticancer drugs.
Petronelli A; Pannitteri G; Testa U
Anticancer Drugs; 2009 Nov; 20(10):880-92. PubMed ID: 19745720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
